Bio-Path (BPTH) Stock Price Down 7%

Bio-Path Holdings (NASDAQ:BPTH)’s share price was down 7% on Thursday . The company traded as low as $2.00 and last traded at $2.14. Approximately 431,654 shares changed hands during mid-day trading, an increase of 45% from the average daily volume of 297,826 shares. The stock had previously closed at $2.00.

Separately, ValuEngine upgraded shares of Bio-Path from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd.

How to Become a New Pot Stock Millionaire

The stock has a market capitalization of $22.68, a P/E ratio of -2.52 and a beta of 2.73.

Hedge funds and other institutional investors have recently modified their holdings of the business. Renaissance Technologies LLC boosted its position in shares of Bio-Path by 64.9% during the 4th quarter. Renaissance Technologies LLC now owns 683,900 shares of the company’s stock worth $138,000 after purchasing an additional 269,200 shares in the last quarter. Hudson Bay Capital Management LP purchased a new stake in shares of Bio-Path during the 4th quarter worth $157,000. Anson Funds Management LP purchased a new stake in shares of Bio-Path during the 4th quarter worth $272,000. Finally, Sabby Management LLC purchased a new stake in shares of Bio-Path during the 4th quarter worth $371,000.

COPYRIGHT VIOLATION WARNING: “Bio-Path (BPTH) Stock Price Down 7%” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3336945/bio-path-bpth-stock-price-down-7.html.

About Bio-Path

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused antisense drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.

Receive News & Ratings for Bio-Path Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Path and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

DigitalNote Price Hits $0.0140 on Top Exchanges
DigitalNote Price Hits $0.0140 on Top Exchanges
BitCoal  Price Tops $0.0209
BitCoal Price Tops $0.0209
Reviewing NGL Energy Partners  & Macquarie Infrastructure
Reviewing NGL Energy Partners & Macquarie Infrastructure
Comparing Encore Capital Group  & CPI Card Group
Comparing Encore Capital Group & CPI Card Group
Financial Survey: Research Frontiers  and Its Rivals
Financial Survey: Research Frontiers and Its Rivals
Reviewing Skyworks Solutions  & Sigma Designs
Reviewing Skyworks Solutions & Sigma Designs


© 2006-2018 Ticker Report. Google+.